Rocket Pharmaceuticals, Inc.
RCKT
$3.39
-$0.15-4.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -68.92M | -61.33M | -60.33M | -66.72M | -69.65M |
| Total Depreciation and Amortization | 2.58M | 2.99M | 2.36M | 2.39M | 2.37M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.65M | 8.26M | 11.74M | 9.40M | 6.21M |
| Change in Net Operating Assets | 8.73M | -5.70M | -717.00K | 2.83M | 7.24M |
| Cash from Operations | -48.96M | -55.79M | -46.94M | -52.10M | -53.82M |
| Capital Expenditure | -50.00K | -364.00K | -309.00K | -1.59M | -1.93M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 31.81M | -57.67M | -37.56M | 80.51M | 57.55M |
| Cash from Investing | 31.76M | -58.04M | -37.87M | 78.92M | 55.62M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 182.85M | 176.00K | 1.53M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 215.00K | -- | -- | -- | -- |
| Cash from Financing | 215.00K | -- | 182.85M | 176.00K | 1.53M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.99M | -113.83M | 98.04M | 26.99M | 3.33M |